Paper Details
- Home
- Paper Details
Association between HLA-B*5901 and methazolamide-induced Stevens-Johnson syndrome/toxic epidermal necrolysis: a systematic review and meta-analysis.
Author: LohitnavyManupat, TangamornsuksanWimonchat
Original Abstract of the Article :
Methazolamide-induced Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) are life-threatening adverse drug reactions. Based on previous studies, HLA genotypes may play an important role in methazolamide-induced SJS/TEN. Therefore, to identify the associations between HLA genotypes and...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1038/s41397-018-0052-2
データ提供:米国国立医学図書館(NLM)
Methazolamide and Stevens-Johnson Syndrome: A Genetic Connection in the Sand
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), like a sudden sandstorm, can wreak havoc on the skin. This study investigates the [genetic factors] associated with [methazolamide-induced SJS/TEN], a severe adverse drug reaction. The authors conduct a [systematic review and meta-analysis] to identify potential [HLA genotypes] that may increase the risk of this condition.
The study found a statistically significant association between the [HLA-B*5901] genotype and [methazolamide-induced SJS/TEN] in [Asian populations]. This is like uncovering a hidden oasis in the desert, revealing a specific genetic vulnerability that may contribute to the development of this serious condition. The authors recommend [genetic screening] for the [HLA-B*5901] genotype before initiating [methazolamide therapy] in [Asian individuals] to minimize the risk of [SJS/TEN].
A Genetic Guide Through the Desert of Adverse Reactions
This study highlights the importance of [personalized medicine] and the potential for [genetic testing] to improve [drug safety]. It’s like using a map to navigate the desert, understanding the terrain and potential hazards to avoid dangerous routes.
Navigating the Desert of Drug Reactions
This research emphasizes the need for [awareness] of the potential [genetic factors] that can influence drug reactions. It’s a reminder that not everyone reacts to medications in the same way, and personalized approaches to treatment can improve patient outcomes. If you experience any adverse reactions to medications, it’s crucial to consult with a healthcare professional for appropriate management.
Dr.Camel's Conclusion
This study is a reminder that the desert of drug reactions can be treacherous. By understanding the genetic factors that influence our response to medications, we can navigate this terrain more safely and make informed decisions about our healthcare.
Date :
- Date Completed 2020-02-07
- Date Revised 2022-12-07
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.